{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:34:35Z","timestamp":1786988075734,"version":"build-2736575974"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ejmech.2025.117515","type":"journal-article","created":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T02:19:12Z","timestamp":1743214752000},"page":"117515","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Discovery of novel 1,2,3-Triazole hybrids derivatives as vasorelaxant agents: Molecular structure, Hirshfeld surface, in-vivo and in-silico investigation by molecular docking simulation"],"prefix":"10.1016","volume":"291","author":[{"given":"Yassine","family":"Rhazi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismail","family":"Bouadid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmae","family":"Nakkabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usama","family":"Raza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lohith Tumakuru","family":"Nagarajappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noemi","family":"Deak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Soran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"El Yazidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa","family":"Alaqarbeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdessamad","family":"Tounsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0394-1533","authenticated-orcid":false,"given":"Mohamed Anouar","family":"Harrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Eddouks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.117515_bib1","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00421-014-2823-z","article-title":"Blood pressure regulation XI: overview and future research directions","volume":"114","author":"Raven","year":"2014","journal-title":"Eur. J. Appl. Physiol."},{"key":"10.1016\/j.ejmech.2025.117515_bib2","series-title":"Global Atlas on Cardiovascular Disease Prevention and Control","author":"Mendis","year":"2011"},{"key":"10.1016\/j.ejmech.2025.117515_bib3","series-title":"WHO. A Global Brief on Hypertension","year":"2013"},{"key":"10.1016\/j.ejmech.2025.117515_bib4","first-page":"257","article-title":"Complications of hypertension as encountered by primary care physician","volume":"101","author":"Biswas","year":"2003","journal-title":"J. Indian Med. Assoc."},{"key":"10.1016\/j.ejmech.2025.117515_bib5","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.yrtph.2016.01.003","article-title":"Pharmacokinetic-pharmacodynamic analyses of antihypertensive drugs, nifedipine and propranolol, in spontaneously hypertensive rats to investigate characteristics of effect and side effects","volume":"76","author":"Kiriyama","year":"2016","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117515_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.chphi.2024.100502","article-title":"Computational integration for antifungal 1,2,4-triazole inhibitors design: QSAR, molecular docking, molecular dynamics simulations, ADME\/Tox, and retrosynthesis studies","volume":"8","author":"Bouamrane","year":"2024","journal-title":"Chem. Phys. Impact"},{"key":"10.1016\/j.ejmech.2025.117515_bib7","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00044-010-9374-6","article-title":"Design, synthesis and pharmacological screening of hybrid molecules as antihypertensives","volume":"20","author":"Acharjee","year":"2011","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2025.117515_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2022.116706","article-title":"Recent advances in the development of active hybrid molecules in the treatment of cardiovascular diseases","volume":"62","author":"Singh","year":"2022","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117515_bib9","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1016\/j.bmc.2019.05.004","article-title":"Design, synthesis and biological evaluation of isochroman-4-one hybrids bearing piperazine moiety as antihypertensive agent candidates","volume":"27","author":"Xie","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117515_bib10","doi-asserted-by":"crossref","first-page":"41353","DOI":"10.1039\/D0RA06642G","article-title":"Recent advances in the pharmacological diversification of quinazoline\/quinazolinone hybrids","volume":"10","author":"Auti","year":"2020","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2025.117515_bib11","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.1016\/j.ejmech.2010.06.013","article-title":"Design, synthesis and biological evaluation of novel quinazoline derivatives as potential antitumor agents: molecular docking study","volume":"45","author":"El-Azab","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117515_bib12","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1016\/j.ejmech.2011.03.015","article-title":"Synthesis and in vitro antitumor activity of substituted quinazoline and quinoxaline derivatives: search for anticancer agent","volume":"46","author":"Noolvi","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117515_bib13","first-page":"306","article-title":"Synthesis and pharmacological investigation of some novel 2-phenyl-3-(substituted methyl amino) quinazolin-4(3H)-ones as H1-receptor blockers","volume":"57","author":"Alagarsamy","year":"2002","journal-title":"Pharmazie"},{"key":"10.1016\/j.ejmech.2025.117515_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003495-199754010-00001","article-title":"Primary prevention of coronary heart disease","volume":"54","author":"Maher","year":"1997","journal-title":"Drugs"},{"key":"10.1016\/j.ejmech.2025.117515_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.128453","article-title":"New bis- and tetrakis-1,2,3-triazole derivatives: synthesis, DNA cleavage, molecular docking, antimicrobial, antioxidant activity and acid dissociation constants","volume":"55","author":"Nural","year":"2022","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2025.117515_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104441","article-title":"Synthesis, biological properties, and acid dissociation constant of novel naphthoquinone\u2013triazole hybrids","volume":"105","author":"Nural","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117515_bib17","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ejmech.2017.05.057","article-title":"Azide-alkyne cycloaddition towards 1H-1,2,3-triazole-tethered gatifloxacin and isatin conjugates: design, synthesis and in vitro anti-mycobacterial evaluation","volume":"138","author":"Xu","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117515_bib18","doi-asserted-by":"crossref","first-page":"22313","DOI":"10.1021\/acsomega.9b02286","article-title":"Efficient rapid access to biginelli for the multicomponent synthesis of 1,2,3,4-tetrahydropyrimidines in room-temperature diisopropyl ethyl ammonium acetate","volume":"4","author":"Jadhav","year":"2019","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejmech.2025.117515_bib19","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1002\/jhet.3286","article-title":"Design, synthesis and SAR study of novel spiro [Pyrimido[5,4-b]Quinoline-10,5\u2032-Pyrrolo[2,3-d]Pyrimidine] derivatives as promising anticancer agents","volume":"55","author":"Chate","year":"2018","journal-title":"J. Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2025.117515_bib20","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2174\/092986711794480113","article-title":"New lead structures in antifungal drug discovery","volume":"18","author":"Sheng","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117515_bib21","author":"Neu"},{"key":"10.1016\/j.ejmech.2025.117515_bib22","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/jac\/25.4.567","article-title":"Inhibition of \u03b2-lactamases by tazobactam and in-vitro antibacterial activity of tazobactam combined with piperacillin","volume":"25","author":"Higashitani","year":"1990","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2025.117515_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/S0090-9556(25)07432-X","article-title":"Identification and characterization of human metabolites of CAI [5-amino-1-1(4\u2019-chlorobenzoyl-3,5-dichlorobenzyl)-1,2,3-triazole- 4-carboxamide)","volume":"24","author":"Soltis","year":"1996","journal-title":"Drug Metabol. Dispos."},{"key":"10.1016\/j.ejmech.2025.117515_bib24","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.3390\/molecules29143366","article-title":"Efficient synthesis, structural characterization, antibacterial assessment, ADME-Tox analysis, molecular docking and molecular dynamics simulations of new functionalized isoxazoles","volume":"29","author":"Arzine","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117515_bib25","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ejmech.2017.09.069","article-title":"An insight into the biological activities of heterocyclic\u2013fatty acid hybrid molecules","volume":"141","author":"Venepally","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117515_bib26","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ejmech.2017.05.057","article-title":"Azide-alkyne cycloaddition towards 1H-1,2,3-triazole-tethered gatifloxacin and isatin conjugates: design, synthesis and in vitro anti-mycobacterial evaluation","volume":"138","author":"Xu","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117515_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202300024","article-title":"1,2,3-Triazole derivatives as an emerging scaffold for antifungal drug development against Candida albicans: a comprehensive review","volume":"20","author":"Singh","year":"2023","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.ejmech.2025.117515_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/ph17101390","article-title":"New quinazolin-4(3H)-One derivatives incorporating isoxazole moiety as antioxidant agents: synthesis, structural characterization, and theoretical DFT mechanistic study","volume":"17","author":"Rhazi","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2025.117515_bib29","first-page":"1","article-title":"Chemoinformatics study of benzodiazepine-1, 2, 3-triazole derivatives targeting butyrylcholinesterase","author":"El Allouche","year":"2024","journal-title":"J. Fluoresc."},{"key":"10.1016\/j.ejmech.2025.117515_bib30","doi-asserted-by":"crossref","first-page":"969","DOI":"10.3390\/chemistry4030066","article-title":"Novel quinazolinone\u2013isoxazoline hybrids: synthesis, spectroscopic characterization, and DFT mechanistic study","volume":"4","author":"Rhazi","year":"2022","journal-title":"Chemistry"},{"key":"10.1016\/j.ejmech.2025.117515_bib31","doi-asserted-by":"crossref","first-page":"969","DOI":"10.3390\/chemistry4030066","article-title":"Novel quinazolinone\u2013isoxazoline hybrids: synthesis, spectroscopic characterization, and DFT mechanistic study","volume":"4","author":"Rhazi","year":"2022","journal-title":"Chemistry"},{"key":"10.1016\/j.ejmech.2025.117515_bib32","author":"Xu"},{"key":"10.1016\/j.ejmech.2025.117515_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.131420","article-title":"Docking of disordered independent molecules of novel crystal structure of (N-(4-methoxyphenyl)-2-(3-methyl-2-oxo-3,4-dihydroquinoxalin-1(2H)-yl)acetamide as anti-COVID-19 and anti-Alzheimer\u2019s disease. Crystal structure, HSA\/DFT\/XRD","volume":"1247","author":"Missioui","year":"2022","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2025.117515_bib34","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1107\/S2053229614024218","article-title":"Crystal structure refinement with SHELXL","volume":"71","author":"Sheldrick","year":"2015","journal-title":"Acta Crystallogr C Struct Chem"},{"key":"10.1016\/j.ejmech.2025.117515_bib35","first-page":"c34","article-title":"PLATON, an integrated tool for the analysis of the results of a single crystal structure determination","volume":"46","author":"Spek","year":"1990","journal-title":"Acta Crystallogr. A"},{"key":"10.1016\/j.ejmech.2025.117515_bib36","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1107\/S1600576719014092","article-title":"Mercury 4.0: from visualization to analysis, design and prediction","volume":"53","author":"Macrae","year":"2020","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.ejmech.2025.117515_bib37","volume":"vol. 62","author":"Jayatilaka","year":"2006"},{"key":"10.1016\/j.ejmech.2025.117515_bib38","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1039\/B818330A","article-title":"Hirshfeld surface analysis","volume":"11","author":"Spackman","year":"2009","journal-title":"CrystEngComm"},{"key":"10.1016\/j.ejmech.2025.117515_bib39","article-title":"Structural elucidation, Hirshfeld surface, DFT, molecular docking and molecular dynamics studies of a novel thiazole derivative as anti-cancer drug","volume":"1324","author":"S","year":"2025","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2025.117515_bib40","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ejmech.2025.117515_bib41","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1021\/jm901495t","article-title":"New fluorinated 1,2,4-benzothiadiazine 1,1-dioxides: discovery of an orally active cognitive enhancer acting through potentiation of the 2-Amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionic acid receptors","volume":"53","author":"Francotte","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117515_bib42","unstructured":"W.L. Delano, PyMOL: an Open-Source Molecular Graphics Tool, (n.d.)."},{"key":"10.1016\/j.ejmech.2025.117515_bib43","doi-asserted-by":"crossref","DOI":"10.2174\/0118715257251651231212045407","article-title":"Antihypertensive and ACE-2 inhibitory effects of daphne gnidium in rats","volume":"22","author":"Bouadid","year":"2024","journal-title":"Cardiovasc. Hematol. Agents Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117515_bib44","article-title":"Chromone-isoxazole hybrids molecules: synthesis, spectroscopic, MEDT, ELF, antibacterial, ADME-Tox, molecular docking and MD simulation investigations","author":"Kanzouai","year":"2023","journal-title":"J. Biomol. Struct. Dyn."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425002806?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425002806?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T04:37:53Z","timestamp":1778042273000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425002806"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":44,"alternative-id":["S0223523425002806"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117515","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of novel 1,2,3-Triazole hybrids derivatives as vasorelaxant agents: Molecular structure, Hirshfeld surface, in-vivo and in-silico investigation by molecular docking simulation","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117515","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117515"}}